Search Results - Castillo, Majin

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study

    Efficacy and safety of febuxostat extended release and immediate release in patients with gout and moderate renal impairment: phase II placebo-controlled study by Gunawardhana, Lhanoo, Becker, Michael A, Whelton, Andrew, Hunt, Barbara, Castillo, Majin, Saag, Kenneth

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo‐Controlled Study

    Efficacy and Safety of Febuxostat Extended and Immediate Release in Patients With Gout and Renal Impairment: A Phase III Placebo‐Controlled Study by Saag, Kenneth G., Becker, Michael A., Whelton, Andrew, Hunt, Barbara, Castillo, Majin, Kisfalvi, Krisztina, Gunawardhana, Lhanoo

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in an Outcomes Trial

    Evaluation of the Relationship Between Serum Urate Levels, Clinical Manifestations of Gout, and Death From Cardiovascular Causes in Patients Receiving Febuxostat or Allopurinol in... by Saag, Kenneth G., Becker, Michael A., White, William B., Whelton, Andrew, Borer, Jeffrey S., Gorelick, Philip B., Hunt, Barbara, Castillo, Majin, Gunawardhana, Lhanoo, Lloyd, Eric, Wigfield, Simon, Gwynne, Lauren, Johnson, Danielle

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Evaluation of Serum Urate Levels and the Clinical Manifestation of Gout with Cardiovascular Mortality from the CARES Trial

    Evaluation of Serum Urate Levels and the Clinical Manifestation of Gout with Cardiovascular Mortality from the CARES Trial by Saag, Kenneth G, Becker, Michael A, White, William B, Whelton, Andrew, Borer, Jeffrey S, Gorelick, Philip B, Hunt, Barbara, Castillo, Majin, Gunawardhana, Lhanoo

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    P-139 PYRAMID Registry: An Observational Study of Adalimumab in Crohnʼs Disease

    P-139 PYRAMID Registry: An Observational Study of Adalimumab in Crohnʼs Disease by DʼHaens, Geert, Reinisch, Walter, Satsangi, Jack, Loftus, Edward, Panaccione, Remo, Castillo, Majin, Kan-Dobrosky, Natalia, Eichner, Samantha, Thakkar, Roopal

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Baseline C-reactive protein is associated with disease progression in patients with Crohnʼs disease: P-34

    Baseline C-reactive protein is associated with disease progression in patients with Crohnʼs disease: P-34 by Colombel, Jean-Frédéric, Sandborn, William, Castillo, Majin, Huang, Bidan, Zhou, Qian, Thakkar, Roopal

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Exploring the use of adalimumab for patients with moderate Crohn's disease: Subanalyses from induction and maintenance trials

    Exploring the use of adalimumab for patients with moderate Crohn's disease: Subanalyses from induction and maintenance trials by Sandborn, William J., Colombel, Jean-Frederic, Panés, Julian, Castillo, Majin, Robinson, Anne M., Zhou, Qian, Yang, Mei, Thakkar, Roopal

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: